1.Balasubramaniam GV.Nagalakshmi V, Anand D. A pilot study on platelets in type II Diabetes Mellitus. Indian J Med Healthcare. 2012;1(3):46-49. |
|
2.Ferroni P, Basili S, Falco A, Davi G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004; 2: 1282–91. |
|
3.Guven, F. , Yilmaz, A. , Aydin, H. and Korkmaz, I. (2010) Platelet aggregation responses in type 2 diabetic patients. Health. 2010;2(7):708-712. [DOI via Crossref] |
|
4.Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet Dysfunction in Type 2.Diabetes Care. 2001;24(8):1476-85. [DOI via Crossref] [Pubmed] |
|
5.Abdulrahaman Y, Dallatu MK. Evaluation of Prothrombin Time and Activated Partial Thromboplastin in Patients with Diabetes Mellitus. Nigerian Journal of Basic and Applied Science. 2012;20(1): 60-63. |
|
6.Sauls DL, Banini AE, Boyd LC, Hoffman M. Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes. J Thromb Haemost. 2007; 5: 638–9. |
|
7.Zhao Y, Zhang J, Zhang J, Wu J. Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values. PLoS One. 2011;6(1):e16470. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
8.Korte W, Clarke S, Lefkowitz JB. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol. 2000;113: 123–127. |
|
9.Hassan FM. Prothrombin Time and Activated PartialThromboplastin Time among type 2 non-insulin dependent Diabetes Mellitus.Recent Journal in Science and Technology.2009;1(3):131-133. |
|
10.Carr ME.Diabetes mellitus: A hypercoagulable state. J Diabetes Complications.2001;15(1):44-54. [DOI via Crossref] |
|